These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36457709)

  • 1. Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and
    Opo FADM; Moulay M; Zari A; Alqaderi A; Alkarim S; Zari T; Bhuiyan MA; Mahmoud MM; Aljoud F; Suhail M; Edris S; Ramadan WS; Kamal MA; Nemmiche S; Ahammad F
    Front Pharmacol; 2022; 13():1027890. PubMed ID: 36457709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
    Greenhalgh J; Dwan K; Boland A; Bates V; Vecchio F; Dundar Y; Jain P; Green JA
    Cochrane Database Syst Rev; 2016 May; (5):CD010383. PubMed ID: 27223332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
    Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
    Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of tripeptides against tyrosine kinase domain of EGFR for lung cancer cell inhibition by in silico and in vitro studies.
    Kiriwan D; Seetaha S; Jiwacharoenchai N; Tabtimmai L; Sousa SF; Songtawee N; Choowongkomon K
    Chem Biol Drug Des; 2022 Mar; 99(3):456-469. PubMed ID: 34923743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors.
    Saeed MEM; Yücer R; Dawood M; Hegazy MF; Drif A; Ooko E; Kadioglu O; Seo EJ; Kamounah FS; Titinchi SJ; Bachmeier B; Efferth T
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancer.
    El Guerrab A; Zegrour R; Nemlin CC; Vigier F; Cayre A; Penault-Llorca F; Rossignol F; Bignon YJ
    PLoS One; 2011; 6(9):e25080. PubMed ID: 21966417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel natural drug candidates against BRAF mutated carcinoma; An integrative in-silico structure-based pharmacophore modeling and virtual screening process.
    Dain Md Opo FA; Alsaiari AA; Rahman Molla MH; Ahmed Sumon MA; Yaghmour KA; Ahammad F; Mohammad F; Simal-Gandara J
    Front Chem; 2022; 10():986376. PubMed ID: 36267655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of phytochemicals from
    Yasmeen N; Ahmad Chaudhary A; K Niraj RR; Lakhawat SS; Sharma PK; Kumar V
    J Biomol Struct Dyn; 2023 Dec; ():1-43. PubMed ID: 38141177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marine-derived sea urchin compounds as potential anti-cancer drug candidate against colorectal cancer:
    Molla MHR; Aljahdali MO
    Saudi J Biol Sci; 2023 Sep; 30(9):103748. PubMed ID: 37560480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, Molecular Docking, and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide Tail as EGFR Kinase Inhibitors.
    Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Firdaus JU; Rahman S; Jha M; Sheikh AA
    Anticancer Agents Med Chem; 2021; 21(1):42-60. PubMed ID: 32718297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Phytocompounds from Common Indian Spices for Identification of Three Potential Inhibitors of Breast Cancer: A Molecular Modelling Approach.
    Hazra S; Ray AS; Rahaman CH
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid Pharmacophore- and Structure-Based Virtual Screening Pipeline to Identify Novel EGFR Inhibitors That Suppress Non-Small Cell Lung Cancer Cell Growth.
    Weng CW; Wei CH; Tsai JY; Lai YH; Chang GC; Chen JJW
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico screening of chalcone derivatives as promising EGFR-TK inhibitors for the clinical treatment of cancer.
    Mathpal S; Joshi T; Sharma P; Maiti P; Nand M; Pande V; Chandra S
    3 Biotech; 2024 Jan; 14(1):18. PubMed ID: 38130684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural alkaloids targeting EGFR in non-small cell lung cancer: Molecular docking and ADMET predictions.
    Saini N; Grewal AS; Lather V; Gahlawat SK
    Chem Biol Interact; 2022 May; 358():109901. PubMed ID: 35341731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Screening of Synthetic and Natural Compounds to Inhibit the Binding Capacity of Heavy Metal Compounds against EGFR Protein of Lung Cancer.
    Ayaz Z; Zainab B; Rashid U; Darwish NM; Gatasheh MK; Abbasi AM
    Biomed Res Int; 2022; 2022():2941962. PubMed ID: 35607306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening of natural compounds as inhibitors of EGFR 696-1022 T790M associated with non-small cell lung cancer.
    Nand M; Maiti P; Pant R; Kumari M; Chandra S; Pande V
    Bioinformation; 2016; 12(6):311-317. PubMed ID: 28293073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors.
    Srour AM; Ahmed NS; Abd El-Karim SS; Anwar MM; El-Hallouty SM
    Bioorg Med Chem; 2020 Sep; 28(18):115657. PubMed ID: 32828424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights.
    Al-Warhi T; El Kerdawy AM; Said MA; Albohy A; Elsayed ZM; Aljaeed N; Elkaeed EB; Eldehna WM; Abdel-Aziz HA; Abdelmoaz MA
    Drug Des Devel Ther; 2022; 16():1457-1471. PubMed ID: 35607598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines.
    Solmi R; Lauriola M; Francesconi M; Martini D; Voltattorni M; Ceccarelli C; Ugolini G; Rosati G; Zanotti S; Montroni I; Mattei G; Taffurelli M; Santini D; Pezzetti F; Ruggeri A; Castellani G; Guidotti L; Coppola D; Strippoli P
    BMC Cancer; 2008 Aug; 8():227. PubMed ID: 18691415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.